Drug Safety Panel Urges New Entity To Oversee Japan Drug Approvals
This article was originally published in The Pink Sheet Daily
Executive Summary
The independent, neutral body would be charged with monitoring, inspecting and investigating MHLW, the Pharmaceutical and Medical Devices Agency and other government administrative functions.
You may also be interested in...
India Price Regulator Wants At Least Five Drug Makers Charged
India's regulator of drug prices has called for legal action against five pharmaceutical companies on charges they violated price controls. The National Pharmaceutical Pricing Authority said the companies collectively sold 39 specified pack sizes of different drugs without prior approval of the prices. The firms named were Alembic, Cadilla Healthcare, Medley Pharmaceuticals, Lupin and Wockhardt. The NPPA said it also is looking at nearly 30 other cases of alleged overcharges and is asking the firms involved to repay the excess amounts. It asked state governments to begin prosecution proceedings. (Click here for more
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products